This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): ABT-384
Description: ABT-384 is 11-beta-hydroxysteroid type I (HSD-1) inhibitor.
Evidence from experiments in transgenic mice and selective HSD-1 inhibitors suggest that decreasing intracellular cortisol in the hippocampus and other brain regions enhances synaptic plasticity and improves memory, including episodic memory.
Additional information available to subscribers only: